First People's Hospital Of Hangzhou
Clinical trials sponsored by First People's Hospital Of Hangzhou, explained in plain language.
-
New hope for hepatitis b moms: drug may shield babies from infection
Disease control Recruiting nowThis study tests the drug TAF in 50 pregnant women with chronic hepatitis B to see if it safely reduces the virus and prevents passing it to their babies. Women take one tablet daily from week 28-32 of pregnancy until delivery. Researchers will measure drug levels in blood and br…
Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New stomach bug treatment battle: which drug combo wins?
Disease control Recruiting nowThis study tests two different 14-day treatments for Helicobacter pylori, a bacteria that can cause stomach ulcers. About 240 adults with confirmed infection will take either tegoprazan or vonoprazan, both combined with amoxicillin. The goal is to see if the newer tegoprazan comb…
Phase: PHASE2, PHASE3 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New study tracks Real-World outcomes of Clot-Removing procedures in legs
Knowledge-focused Recruiting nowThis study follows 400 people with acute or subacute blood clots in leg arteries who undergo endovascular treatment (minimally invasive procedures like thrombectomy or catheter-directed thrombolysis). Researchers track how many patients avoid amputation and survive, as well as co…
Sponsor: First People's Hospital of Hangzhou • Aim: Knowledge-focused
Last updated Jun 24, 2026 09:05 UTC
-
Tiny study probes Electroacupuncture's immune effects in shingles
Knowledge-focused Recruiting nowThis study looks at how electroacupuncture might affect immune cells in people with shingles (herpes zoster). Researchers will compare standard medication alone versus medication plus electroacupuncture in 8 women aged 50-70. The goal is to see if electroacupuncture changes immun…
Phase: NA • Sponsor: First People's Hospital of Hangzhou • Aim: Knowledge-focused
Last updated Jun 24, 2026 09:03 UTC
-
Scientists dive deep into rare lung Cancer's genetic and immune secrets
Knowledge-focused Recruiting nowThis study examines tumor samples from 39 Chinese patients with a rare lung cancer called signet ring cell carcinoma. Researchers will analyze genes and immune cells to build a detailed molecular database. A small group with specific genetic changes will also receive targeted dru…
Sponsor: First People's Hospital of Hangzhou • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:00 UTC